


Searching News Database: Marker Therapeutics
HSMN NewsFeed - 1 May 2025
Altesa BioSciences announces Katharine Knobil, M.D. as Chief Medical Officer
Altesa BioSciences announces Katharine Knobil, M.D. as Chief Medical Officer
HSMN NewsFeed - 7 Feb 2019
Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development
Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development
